oxiconazole has been researched along with bay h 4502 in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A | 1 |
Bron, S; Chambon, M; Colau, D; Majjigapu, SR; Michielin, O; Pilotte, L; Röhrig, UF; Turcatti, G; Van den Eynde, BJ; Vogel, P; Zoete, V | 1 |
Bozkurt, M; Gürer, MA; Kuştimur, S | 1 |
Frosch, PJ; Raulin, C | 1 |
Cauwenbergh, G | 1 |
Reckers-Czaschka, R; Wagner, W | 1 |
Abbott, AB; Odds, FC; Webster, CE | 1 |
Polak, A | 1 |
1 trial(s) available for oxiconazole and bay h 4502
Article | Year |
---|---|
[Oxiconazole in dermatomycosis--a double-blind, randomized therapy compared with bifonazole].
Topics: Adult; Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Double-Blind Method; Erythrasma; Female; Humans; Imidazoles; Male; Random Allocation | 1987 |
7 other study(ies) available for oxiconazole and bay h 4502
Article | Year |
---|---|
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity | 2012 |
Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Topics: Animals; Antifungal Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship | 2014 |
[In vitro susceptibility of dermatophyte strains to imidazole derivatives].
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Humans; Imidazoles; Miconazole | 1989 |
Contact allergy to imidazole antimycotics.
Topics: Adult; Aged; Antifungal Agents; Chemical Phenomena; Chemistry; Clotrimazole; Drug Eruptions; Econazole; Female; Humans; Imidazoles; Male; Miconazole; Middle Aged; Prospective Studies | 1988 |
New and prospective developments in antifungal drugs.
Topics: Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Compounding; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Terbinafine; Triazoles | 1986 |
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
Topics: Antifungal Agents; Aspergillus; Candida; Clotrimazole; Econazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Morpholines; Triazoles | 1984 |
Antifungal activity of four antifungal drugs in the cutaneous retention time test.
Topics: Animals; Antifungal Agents; Guinea Pigs; Imidazoles; Morpholines; Ointments; Thiocarbamates; Tinea; Trichophyton | 1984 |